Advertisement Henry Ford Hospital initiates emphysema trial - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

Henry Ford Hospital initiates emphysema trial

Henry Ford Hospital has started the Ease trial, an international, multi-center clinical trial to explore an investigational treatment that may offer a significant new option for those suffering with advanced emphysema.

The study focuses on a new procedure, called airway bypass, that involves creating pathways in the lung for trapped air (one of the primary causes of shortness breath) to escape. Henry Ford is said to be the only hospital in Detroit participating in the study.

Patients eligible for the study must be older than 35, non-smokers and be diagnosed with advanced widespread emphysema. They will receive all medical procedures at no cost, receive at least 14 weeks of pulmonary rehabilitation therapy and have eight to 16 physician appointments.

Michael Simoff, principal investigator of the study, said: “The airway bypass procedure could be an excellent option for those who are not suitable candidates for lung transplant surgery or as a bridge for those who could possibly spend years on a lung transplant list.”